Human embryonic stem cells (hESCs) [4] [5] [6] , endothelial cells [7, 8] , vascular smooth muscle cells [9] [10] [11] 
Introduction

Human embryonic stem cells (hESCs) are characterized by their capacity for self-renewal and their potential to generate almost all cell types. Thus, they are considered to be a promising and unlimited source of cellular transplantation and tissue engineering. However, the development of a serum-free, xeno-free medium that supports the derivation, large-scale propagation and long-term culture of hESCs is still one of the major hurdles for their clinical utility. Therefore, understanding the molecular mechanisms that control hESC self-renewal, and the identification of molecules and factors in this self-renewal, is crucial. Various molecules have been studied to develop defined culture conditions for hESCs, but so far the role of neuropeptide Y (NPY) signalling through G protein-coupled receptors (GPCRs) has not been investigated. NPY, one of the most abundant neuropeptides in the brain, is a highly conserved 36-residue peptide that is structurally similar to peptide YY and pancreatic polypeptide
. The proteolytic processing of proNPY, the 69-amino acid precursor protein, leads to the mature secreted form of NPY. The amino acid sequence of mature human and mouse NPY are identical, while porcine NPY (leucine at position 17) and human NPY (methionine at position 17) differ in a single amino acid; however, this difference does not seem to affect the biological activity of NPY [3] .
The growth factor properties of NPY were demonstrated in various cell types including neurons [4] [5] [6] , endothelial cells [7, 8] , vascular smooth muscle cells [9] [10] [11] and adipocyte precursor cells [12] . The Table S1 . Fig. 2A-C (Fig. 3A) and the diminished expression of hESC markers ( Fig. 3A (Fig. S1A) 
Materials and methods
Reagents
Human NPY (Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-AlaGlu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-ThrArg-Gln-Arg-Tyr-NH2; Sigma, St. Louis, MO, USA), two random-sequence control peptides (SC-10; N-WFGDVNQKPI-C, SC-36; N-SNSRPPRKND-VNTMADAYKFLQDLDTYYGDRAR VRF-C) (PepTron
inhibitor (U0126) (Calbiochem) and PKA inhibitor (H89) (Calbiochem) were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 10 mM, and stored as aliquot in the deep-freezer (-70ЊC). Prior to use, they were diluted with culture medium to yield the desired concentrations (3-10 M). Control cultures were incubated with 0.1% (v/v) DMSO alone or PBS. In our experiments, the DMSO concentration in all test media did not exceed 0.1%. NPY antagonists and kinase inhibitors were added to culture dish on a daily basis unless otherwise indicated. Peptides and antagonists used in this study are listed in
hESC culture
Two hESC lines H9 (NIH Code
,
Embryoid body differentiation
and B). Y1 or Y5 antagonist alone had no notable effects compared to DMSO controls (Fig. S1B). NPY antagonists (3 M) had no cytotoxic effects in hESCs as determined by cell counting
Proliferation of undifferentiated hESCs maintained in NPY medium
To better understand the role of NPY on hESCs, we tested the direct effect of NPY on hESC proliferation by assessing BrdU incorporation. hESCs cultured in UM, which lost their undifferentiated state, displayed a lower rate of BrdU incorporation (24.5 Ϯ 2.3%) when compared with undifferentiated hESCs cultured in MEF-CM (72.4 Ϯ 2.9%; Fig. 4). The addition of 0.5 M NPY to the UM resulted in a significant increase in the BrdU incorporation by
Fig. 1 Expression of NPY and its receptor subtypes on hESCs and MEF feeder cells. (A) Semi-quantitative RT-PCR analysis of mRNA expression for NPY, NPY1R, NPY2R, NPY4R and NPY5R in hESCs (H9 and HES-7) and MEFs. GAPDH was used as a loading control. (B) Immunofluorescent analysis of NPY protein expression in H9 cells and MEFs. Cell nuclei were counterstained with DAPI. Bar ϭ 50 m. (C) Real-time qRT-PCR analysis of mRNA expression of NPY, NPY1R and NPY5R in undifferentiated and differentiated H9 hESCs (RA-differentiated hESCs and differentiating hEBs). The results are displayed as the relative mRNA level with the level in undifferentiated hESCs cultured in MEF-CM referred set to 1 and are presented as the mean Ϯ S.E. (n ϭ 3).
the hESCs, reaching levels comparable to hESCs cultured in MEF-CM (Fig. 4) [11, 12] . Therefore, we further explored whether PI3K/AKT, MAPK/ERK1/2 and PKA signalling is involved in mediating the proliferative effect of NPY on hESCs using pharmacological inhibitors of the respective signalling cascades. As shown in Fig. 4 (Fig. 5A ) and a normal karyotype (Fig. 5B) (Fig. 5D) . The majority of the differentiating NESs expressed the proliferation marker Ki67 
mm (inset images). (B) Karyotype analysis of hESCs cultured in NPY medium for 15 passages. (C) hEB formation and differentiation. hEBs were derived from H9 cells cultured in CM or NPY medium for 15 passages. Upper panel; representative images of hEBs. Bar ϭ 500 m or 1 mm (inset images). Lower panel; real-time RT-PCR analysis for the expression of OCT4 and differentiation markers characteristic of the three germ layers; ectoderm (PAX6 and NCAM), mesoderm (GATA2 and cTnT) and endoderm (␣-FP and GATA6). The data are presented as the mean Ϯ S.E. of three independent experiments. (D) NESs derived from hESCs. Left panel; representative images of NESs. Right panel; RT-PCR analysis of neural stem cell marker expression in NESs. (E) Representative images of NESs stained either for Ki67 (cell proliferation marker), nestin, MSI1 and/or NCAM. Bar ϭ 500 m.
and the neural precursor markers, NES, MSI1 and NCAM (Fig. 5E). These results indicate that hESCs cultured in NPY medium can be successfully differentiated into neural cells and are pluripotent.
A novel chemically defined medium with NPY supplement supports the maintenance of undifferentiated hESCs
The defined N2/B27 supplement, bFGF and TGF-␤1 have been used to replace KSR and to develop a chemically defined medium for hESC culture [19, [22] [23] [24] . (Fig. 6A) (Fig. 6B) . The NPY-mediated AKT activation was inhibited by pre-treatment of with an AKT or ERK1/2 inhibitor, but not with a PKA inhibitor. In contrast, the NPY-mediated ERK activation was blocked by all three inhibitors (Fig. 6C) . (Fig. 6A) . The p-CREB was predominantly localized to the nucleus in NPY-treated hESCs (Fig. 6D) . The pre-treatment with the Y1 antagonist, but not the Y5 antagonist, partially blocked the NPYmediated up-regulation of p-CREB (Fig. 6B and D) . Furthermore, pre-treatment of hESCs with inhibitors specific for AKT, ERK1/2 or PKA blocked the NPY-mediated CREB phosphorylation; however, their ability to inhibit CREB phosphorylation appeared to be incomplete (Fig. 6C) (Fig. 6C) (Fig. 1A and B) . Therefore, NPY most likely mediates its biological effects by interacting with the Y1 and Y5 receptors in hESCs. NPY has shown to possess a virtually identical affinity for both the Y1 and Y5 receptors [25, 26] . Changes in the mRNA expression of NPY, NPY1R and NPY5R receptor mRNA expression level upon hESC differentiation were observed, suggesting that the expression levels appear to be influenced by the differentiation state of the hESC s (Fig. 1C) . NPY is highly conserved, and the sequence of human and mouse NPY is identical [2] . Of [27] and bFGF [28] [29] [30] , all of which have been shown to affect hESC self-renewal and survival [31] [32] [33] (Fig. S3C) . Supportive effect of NPY on the maintenance of undifferentiated hESCs maintained with UM was supplementation frequency-dependent and dose-dependent (Fig. S3A and B) [22, 38, 39] . It is widely accepted that exogenous bFGF and the FGF signalling pathway are required, but not sufficient, for the maintenance of hESC self-renewal and pluripotency when used in a serum-free, chemically defined medium [22, [40] [41] [42] . In our defined conditions, the addition of 1 M NPY to N2/B27 medium containing low concentration of bFGF (20 ng/ml) clearly minimized the spontaneous differentiation of hESCs and was sufficient to maintain hESCs in an undifferentiated state for 6-10 passages. Combinatorial treatment with NPY and TGF-␤1 tend to be more efficient to achieve relatively long-term maintenance of undifferentiated hESCs over 15 passages (Fig. S2A and B) .
We further optimized the serumand feeder-free culture conditions based on combinations of N2/B27, bFGF and TGF-␤1 with or without addition of NPY. In our conditions, hESCs cultured in N2/B27-based medium containing 20 ng/ml bFGF (N2/B27 medium) failed to maintain an undifferentiated state, proliferated less and differentiated to a greater extent. However, the addition of 1 M NPY to N2/B27 medium containing 20 ng/ml bFGF clearly improved the undifferentiated colony morphology, growth efficiency and expression of the hESC markers in hESCs (Fig. S2C and D). Under such conditions, hESCs retained their undifferentiated state for more than six passages, appeared similar way to hESCs cultured in MEF-CM in terms of cell morphology, maintained normal hESC marker expression (Fig. S2A) and retained a normal karyotype (Fig. S2B). Defined N2/B27 medium containing 1 M NPY, but not TGF-␤1, was able to support undifferentiated hESC expansion for 6-10 passages; however, addition of 1 ng/ml TGF-␤1 to defined N2/B27 medium containing 1 M NPY was required for long-term maintenance of undifferentiated hESCs (Ն15 passages) (Fig. S3A and B). The optimum and minimum concentration of NPY required for hESC culture was largely dependent upon the medium composition, but its effect on hESC self-renewal was dose dependent at a range of 0.005-3 M (data not shown). Our results suggest that NPY functions as a positive regulator of hESC self-renewal and that the use of NPY in the culture medium supports the long-term culture of hESCs without feeder cells and serum.
NPY activates multiple pathways including AKT, ERK1/2, PKA and CREB in hESCs
In an attempt to elucidate how NPY regulates hESC self-renewal and proliferation, we evaluated the AKT, ERK1/2, PKA and CREB signal transduction cascades by Western blot using phospho-specific antibodies. In response to NPY, a transient increase in the level of phospho-AKT (pAKT) and phospho-ERK (pERK) in hESCs was observed within 1 min., while the total expression of AKT and ERK was not changed compared to PBS control groups
We further investigated whether CREB signalling is involved in the NPY-mediated signal transduction by determining the expression level of CREB and phospho-CREB (p-CREB). In response to 1 M NPY, hESCs exhibited a rapid increase of p-CREB in 15 min. without a significant change in the total CREB protein level
. Without NPY treatment, kinase inhibitors alone had no notable effects on the expression levels of AKT, ERK and CREB proteins compared to DMSO control groups. PKA, AKT, or ERK1/2 inhibitor induced the decrease in basal levels of p-CREB compared to DMSO control groups. Under our condition, ERK1/2 inhibitor alone induced decrease in basal levels of p-ERK1/2 compared to 0.1% DMSO control groups
The addition of exogenous NPY to hESC culture likely inhibits or attenuates the differentiation of hESCs and also induced undifferentiated proliferation of hESCs (Fig. 4) (Fig. 3C) . In correlation, Y1 and Y5 antagonists fully blocked the NPY's supportive effects on the maintenance of undifferentiated hESCs (Fig. 3A) (Fig. 6E) . Furthermore, inhibitors of AKT, ERK1/2 and PKA partially blocked the NPY-mediated increase in CREB phosphorylation (Fig. 6C) . These results suggest that the NPY-mediated activation of CREB in hESCs is AKT, ERK and PKAdependent (Fig. 6E) . Because the AKT, ERK1/2 and PKA inhibitors did not completely attenuate the NPY-mediated activation of CREB, cross-talk between the pathways in regulating NPY-mediated hESC self-renewal is highly probable (Fig. 6E) [43, 44] . Platelet-derived growth factor (PDGF) promotes intracellular S1P signalling by activating sphingosine kinase, which in turn converts sphingosine to S1P. Pebay et al. showed that extracellular S1P and PDGF blocked spontaneous differentiation of hESCs under serum-free culture condition [45] . In correlation, we determined that activation of NPY signalling differentially modulated the mRNA expression levels of key components of bFGF, TGF-␤/bone morphogenetic protein (BMP) and PDGF signalling pathways (Fig. S4) (Fig. S5) Table S2 . 
